TMC NEWS

TMCNET eNEWSLETTER SIGNUP

SQI Diagnostics Announces Stock Option Grants

SQI Diagnostics Inc. (TSX-Venture: SQD), a life sciences
company that develops and commercializes proprietary technologies and
products for advanced microarray diagnostics, today announced that
effective January 09, 2012, they have granted 70,000 stock options to
each of David Williams, Paul Mountain, Peter Lea, Eric Schneider, Saied
Nadjafi and Peter Winkley and 175,000 stock options to Claude Ricks. All
recipients are members of the Board of Directors.

The options were granted at an exercise price of $0.45. Pursuant to the
previously approved stock option plan, the options have a term of 5
years and vest over an 18 month period.

About SQI DiagnosticsSQI Diagnostics is a life sciences
company that develops and commercializes proprietary technologies and
products for advanced microarray diagnostics. The Company's proprietary
microarray tests and fully-automated systems are designed to simplify
protein and antibody testing workflow, increase throughput, reduce costs
and provide excellent data quality. For more infrmation, please visit www.sqidiagnostics.com

FORWARD-LOOKING INFORMATION

This press release contains certain forward-looking statements,
including, without limitation, statements containing the words "may",
"plan", "will", "estimate", "continue", "anticipate", "intend",
"expect", "believe", "in the process", "is subject to" and other similar
expressions which constitute "forward-looking information" within the
meaning of applicable securities laws. Forward-looking statements
reflect the Company's current expectation and assumptions, and are
subject to a number of risks and uncertainties that could cause actual
results to differ materially from those anticipated. Such statements
reflect the current views of the Company with respect to future events
and are subject to certain risks and uncertainties and other risks
detailed from time-to-time in the Company's ongoing filings with the
securities regulatory authorities, which filings can be found at www.sedar.com.
Actual results, events, and performance may differ materially. Readers
are cautioned not to place undue reliance on these forward-looking
statements. The Company undertakes no obligation to publicly update or
revise any forward-looking statements either as a result of new
information, future events or otherwise, except as required by
applicable securities laws.

Neither TSX Venture Exchange nor its Regulation Services Provider (as
that term is defined in the policies of the TSX Venture Exchange)
accepts responsibility for the adequacy or accuracy of this release.